|
2024-02-02 |
2024-02-01 |
GV
Geplanter Verkauf
|
Simpson Adam K.
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
15.000
-4.0%
15,29
229.386 USD
|
15.000
-4.0%
|
15,29
|
229.386 USD
|
|
|
2024-01-04 |
2024-01-02 |
GV
Geplanter Verkauf
|
Simpson Adam K.
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
15.000
-5.4%
15,67
235.088 USD
|
15.000
-5.4%
|
15,67
|
235.088 USD
|
|
|
2023-12-22 |
2023-12-21 |
V
Verkauf
|
Simpson Adam K.
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
40.000
-13.3%
15,43
617.060 USD
|
40.000
-13.3%
|
15,43
|
617.060 USD
|
|
|
2023-12-22 |
2023-12-21 |
GV
Geplanter Verkauf
|
Simpson Adam K.
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
50.000
-14.3%
15,44
772.220 USD
|
50.000
-14.3%
|
15,44
|
772.220 USD
|
|
|
2023-12-22 |
2023-12-20 |
GV
Geplanter Verkauf
|
Kanesa-thasan Niranjan
Chief Medical Officer
Führungsperson
|
11.884
-5.0%
15,46
183.692 USD
|
11.884
-5.0%
|
15,46
|
183.692 USD
|
|
|
2023-12-22 |
2023-12-20 |
V
Verkauf
|
Russo Thomas Joseph
Chief Financial Officer
Führungsperson
|
4.430
-10.4%
15,47
68.510 USD
|
4.430
-10.4%
|
15,47
|
68.510 USD
|
|
|
2023-12-22 |
2023-12-20 |
GV
Geplanter Verkauf
|
Russo Thomas Joseph
Chief Financial Officer
Führungsperson
|
10.753
-20.2%
15,46
166.210 USD
|
10.753
-20.2%
|
15,46
|
166.210 USD
|
|
|
2023-12-22 |
2023-12-20 |
GV
Geplanter Verkauf
|
Simpson Adam K.
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
62.205
-25.2%
15,46
961.509 USD
|
62.205
-25.2%
|
15,46
|
961.509 USD
|
|
|
2023-12-22 |
2023-12-20 |
GV
Geplanter Verkauf
|
Cearley Cassia
Chief Business Officer
Führungsperson
|
7.934
-5.7%
15,46
122.637 USD
|
7.934
-5.7%
|
15,46
|
122.637 USD
|
|
|
2023-12-15 |
2023-12-13 |
GV
Geplanter Verkauf
|
Cearley Cassia
Chief Business Officer
Führungsperson
|
8.759
-6.3%
16,01
140.190 USD
|
8.759
-6.3%
|
16,01
|
140.190 USD
|
|
|
2023-08-01 |
2023-07-31 |
GV
Geplanter Verkauf
|
Russo Thomas Joseph
Chief Financial Officer
Führungsperson
|
3.066
-6.3%
8,86
27.169 USD
|
3.066
-6.3%
|
8,86
|
27.169 USD
|
|
|
2023-08-01 |
2023-07-31 |
GV
Geplanter Verkauf
|
Simpson Adam K.
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
11.788
-4.6%
8,86
104.459 USD
|
11.788
-4.6%
|
8,86
|
104.459 USD
|
|
|
2023-08-01 |
2023-07-31 |
GV
Geplanter Verkauf
|
Cearley Cassia
Chief Business Officer
Führungsperson
|
1.888
-1.3%
8,86
16.731 USD
|
1.888
-1.3%
|
8,86
|
16.731 USD
|
|
|
2023-08-01 |
2023-07-31 |
GV
Geplanter Verkauf
|
Kanesa-thasan Niranjan
Chief Medical Officer
Führungsperson
|
3.323
-1.4%
8,86
29.447 USD
|
3.323
-1.4%
|
8,86
|
29.447 USD
|
|
|
2023-07-03 |
2023-07-03 |
GV
Geplanter Verkauf
|
Holtzman Douglas
Chief Scientific Officer
Führungsperson
|
2.095
-0.7%
9,59
20.083 USD
|
2.095
-0.7%
|
9,59
|
20.083 USD
|
|
|
2023-07-03 |
2023-07-03 |
GV
Geplanter Verkauf
|
Holtzman Douglas
Chief Scientific Officer
Führungsperson
|
14.261
-4.7%
8,74
124.660 USD
|
14.261
-4.7%
|
8,74
|
124.660 USD
|
|
|
2023-05-25 |
2023-05-23 |
GV
Geplanter Verkauf
|
Cearley Cassia
Chief Business Officer
Führungsperson
|
10.000
-6.6%
10,00
100.000 USD
|
10.000
-6.6%
|
10,00
|
100.000 USD
|
|
|
2023-04-05 |
2023-04-03 |
GV
Geplanter Verkauf
|
Holtzman Douglas
Chief Scientific Officer
Führungsperson
|
300
-0.1%
6,56
1.968 USD
|
300
-0.1%
|
6,56
|
1.968 USD
|
|
|
2023-04-05 |
2023-04-03 |
GV
Geplanter Verkauf
|
Holtzman Douglas
Chief Scientific Officer
Führungsperson
|
20.143
-6.5%
6,08
122.439 USD
|
20.143
-6.5%
|
6,08
|
122.439 USD
|
|
|
2023-03-08 |
2023-03-06 |
GV
Geplanter Verkauf
|
Cearley Cassia
Chief Business Officer
Führungsperson
|
5.000
-3.2%
7,75
38.737 USD
|
5.000
-3.2%
|
7,75
|
38.737 USD
|
|
